Public Inquiry

Infected Blood Inquiry

Status: Completed Chair: Sir Brian Langstaff Established: Sep 2018 Report: May 2024 Commissioned by: Cabinet Office

Examining how thousands of NHS patients were infected with HIV and Hepatitis C through contaminated blood products in the 1970s and 1980s. Found the scandal could largely have been avoided and victims were failed by the NHS, government, and blood …

Response breakdown

103 recommendations total

72%

27%

74 (72%) — Accepted

28 (27%) — Accepted in Part

1 (1%) — Under Review

Reports & milestones

Reports

09 Jul 2025 26 tracked recs Additional Report on Compensation · Tracked recommendations · PDF

20 May 2024 58 tracked recs Infected Blood Inquiry Final Report · Tracked recommendations · PDF

29 Jul 2022 1 tracked rec First Interim Report · Tracked recommendations · PDF

05 Apr 2023 18 tracked recs Second Interim Report · Tracked recommendations · PDF

Timeline

11 Jul 2017 Inquiry Announced Prime Minister Theresa May announced a public inquiry. · Source

11 Jul 2017 Chair Appointed Sir Brian Langstaff appointed as Chair.

25 Jul 2018 Terms of Referenc… Terms of Reference published. · Source

30 Apr 2019 Hearings Begin Public hearings commenced.

19 Jul 2022 First Interim Rep… Interim report on compensation framework. · Source

05 Apr 2023 Second Interim Re… Second interim report with further compensation recommendations.

20 May 2024 Final Report Publ… Final report published finding decades of cover-up. · Source

21 May 2024 Government Apology Prime Minister issued full apology in Parliament. · Source

Recommendations

28 shown (filtered)

Code	Recommendation	Addressed to	Response
IBI-4a(iv)	Individual Duty of Candour for Leaders Statutory duty of candour: The statutory duties of candour in England, Scotland, Wales (and Northern Ireland, when introduced) should be extended to …	UK Government	Accepted in Part	View →
IBI-4a(v)	Leadership Accountability for Safety Statutory duty of candour: Individuals in leadership positions should be required by the terms of their appointment and by secondary legislation to …	UK Government	Accepted in Part	View →
IBI-4b	Organisational Culture Change Cultural Change: That a culture of defensiveness, lack of openness, failure to be forthcoming, and being dismissive of concerns about patient safety …	UK Government	Accepted in Part	View →
IBI-5a	Civil Service Statutory Duty of Candour The Government should reconsider whether, in the light of the facts revealed by this Inquiry, it is sufficient to continue to rely …	UK Government	Accepted in Part	View →
IBI-5b	Monitoring Non-Statutory Duties If, on review, the Government considers that it is sufficient to rely on the current non-statutory duties in the Civil Service Code, …	UK Government	Accepted in Part	View →
IBI-5c	Ministerial Duty of Candour The Government should consider the extent to which Ministers should be subject to a duty beyond their current duty to Parliament under …	UK Government	Accepted in Part	View →
IBI-6a(ii)	Specialist Hepatology Centre Access All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Those who have fibrosis …	UK Government	Accepted in Part	View →
IBI-6a(v)	Consultant Hepatologist Access All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Those who have had …	UK Government	Accepted in Part	View →
IBI-7a(i)	Transfusion Committees and Tranexamic Acid - England In England, Hospital Transfusion Committees and transfusion practitioners take steps to ensure that consideration of tranexamic acid be on every hospital surgical …	UK Government	Accepted in Part	View →
IBI-7c	Transfusion Laboratory Staffing Transfusion laboratories: Transfusion laboratories should be staffed (and resourced) adequately to meet the requirements of their functions.	UK Government	Accepted in Part	View →
IBI-7d	Training in Transfusion Medicine Training in Transfusion Medicine: That those bodies concerned with undergraduate and postgraduate training across the UK of those people who are, or …	UK Government	Accepted in Part	View →
IBI-7e	Implementing SHOT Reports Implementing SHOT reports: That all NHS organisations across the UK have a mechanism in place for implementing recommendations of Serious Hazard of …	UK Government	Accepted in Part	View →
IBI-7f(iii)	Blood Tracking Systems Funding Establishing the outcome of every transfusion: That funding for the provision of enhanced electronic clinical systems in relation to blood transfusion be …	UK Government	Accepted in Part	View →
IBI-10a(iv)	Thalassaemia Society Support Particular consideration be given, together with the UK Thalassaemia Society and the Sickle Cell Society, to how the needs of patients with …	UK Government	Accepted in Part	View →
IBI-11a	Ministerial Power to Call Inquiries That a minister should retain the power to call an inquiry as the minister sees fit, in accordance with the Inquiries Act …	UK Government	Accepted in Part	View →
IBI-11b	Parliamentary Referral to PACAC If there is sufficient support from within Parliament for there to be an inquiry, the question whether there should be one should …	UK Government	Accepted in Part	View →
IBI-11c	PACAC Recommendation Power If it appears to PACAC that there is sufficient concern to justify a public inquiry, either because what happened and why has …	UK Government	Accepted in Part	View →
IBI-11d	Ministerial Reasons for Disagreement If the minister disagrees with the recommendation, they must set out in detail and publish reasons for this disagreement which are sufficient …	UK Government	Accepted in Part	View →
IBI-12d	PACAC Oversight of Implementation The Public Administration and Constitutional Affairs Committee (“PACAC”) should review both the progress towards responding to the Inquiry’s recommendations and, to the …	UK Government	Accepted in Part	View →
IBI-12e	PACAC Role for Future Inquiries PACAC should accept the role in respect of any future statutory inquiry of reviewing the government’s timetable for consideration of recommendations, and …	UK Government	Accepted in Part	View →
IBI-A-4a	Interferon Treatment Impacts People infected with Hepatitis B or C who have received a course of treatment with or based on interferon should be recognised …	UK Government	Accepted in Part	View →
IBI-A-4b	Special Category Mechanism The Government reconsider whether to maintain its rejection in February 2025 of the recommendations of Sir Robert Francis KC and advice from …	UK Government	Accepted in Part	View →
IBI-A-5a	Severe Psychological Harm The approach of the Infected Blood Psychology Service is adopted so that both a diagnosis made by a psychiatric professional and a …	UK Government	Accepted in Part	View →
IBI-A-6a	Financial Loss and Care "x" be removed from the equation set out in Regulation 7.	UK Government	Accepted in Part	View →
IBI-A-6b	Exceptional Loss Evidence The Cabinet Office consult on whether the evidential requirements for exceptional reduced earnings are likely to prove a barrier to people who …	UK Government	Accepted in Part	View →
IBI-A-7a	Unethical Research Award Where there is evidence that an individual was the victim of unethical research practices IBCA should be authorised to make an unethical …	UK Government	Accepted in Part	View →
IBI-A-7b	Wider Definition of Unethical Research When considering the evidence IBCA applies the wider definition of research explained in the Infected Blood Inquiry Additional Report chapter on Unethical …	UK Government	Accepted in Part	View →
IBI-A-8a	Supplementary Route for Affected Persons The Minister give consideration to there being a supplementary route for people affected. This could include opening the supplemental award for severe …	UK Government	Accepted in Part	View →

Parliamentary activity

386 mentions since Sep 2017

52 debates 284 questions 45 statements

15 Jun 2026 Early Day Motion Infected Blood Inquiry compensation
Lisa Smart (Liberal Democrat)

19 May 2026 Written Question Infected Blood Inquiry: Costs
Mike Wood (Conservative)

13 May 2026 Early Day Motion Redress for people impacted by surgical mesh, sodium valproate and Primodos
Sarah Green (Liberal Democrat)

14 Apr 2026 Written Ministerial Statement Update on the Infected Blood Compensation Scheme
Baroness Anderson of Stoke-on-Trent (Labour)

14 Apr 2026 Written Ministerial Statement Update on the Infected Blood Compensation Scheme
Nick Thomas-Symonds (Labour)

View all 386 mentions →

Costs

Total: £146,162,778

Period	Total	Inquiry legal	CP legal	Source
Mar 2025 (cum.)	£146,162,778	£67,290,993	£27,242,761	link
Mar 2025	£5,511,059	£1,514,906	£603,277	link
Mar 2024	£10,301,344	£5,354,237	£937,131	link
Mar 2023	£28,254,992	£11,694,492	£7,154,110	link
Mar 2022	£32,522,939	£15,491,533	£5,778,813	link
Mar 2021	£34,270,948	£20,797,365	£4,505,612	link
Mar 2020	£25,992,907	£9,959,119	£5,742,876	link
Mar 2019	£9,308,693	£2,479,341	£2,520,943	link